Type 1 diabetes

Heme oxygenase-1 polymorphisms associate with ischemic cardiac complications and all-cause mortality in type 1 diabetes

Cardiovasc DiabetolPublished Genetic association study

Authors' conclusion

The LL genotype of the HMOX1 GTn repeat and the AA genotype of -413A/T SNP were associated with ischemic cardiac complications and all-cause mortality in men, but not in women. Thus, the HMOX1 genotype may influence the development of cardiovascular complications in individuals with T1D in a sex-dependent manner.

Study context

Population
Individuals with T1D in the Finnish Diabetic Nephropathy Study (FinnDiane)GTn genotyped n = 3990
Participants
4,278 individuals
Comparison
HMOX1 GTn repeat LL vs SS/SL genotype
Outcome
Vascular complications (ischemic cardiac events) and all-cause mortality

Main finding

As reported in the abstract

Ischemic cardiac events, men

P = 0.001

LL genotype associated with all-cause mortality in men
P = 0.031

Further findings

Ischemic cardiac events, all individuals

P = 0.006

Ischemic cardiac events, women

P = 0.657

OutcomeP value
Serum HO-1 concentration by sexMen vs Women · higher in menP < 0.001
  • Serum HO-1 concentration by sex: Men 3.12 ± 1.23 ng/ml
  • Serum HO-1 concentration by sex: Women 2.64 ± 1.04 ng/ml
  • Serum HO-1 concentration by sex: serum HO-1 measured in n = 861

Ischemic cardiac events, men, −413A/T SNP AA genotype

Men with AA genotype had ischemic cardiac events more frequently (21.0% vs. 17.4%)
P = 0.044
No differences for women or men and women together

+99G/C variant and CV complications

No differences between genotypes regarding CV complications

Serum HO-1 by genotype

No difference in HO-1 serum concentrations between genotypes (GTn, −413A/T or +99G/C)

Serum HO-1 concentration by sex

In women, higher HO-1 associated with CVD and need for antihypertensive and lipid-lowering medications

Original publication

Heme oxygenase-1 polymorphisms associate with ischemic cardiac complications and all-cause mortality in type 1 diabetes. Cardiovasc Diabetol. Published 18 August 2025. doi:10.1186/s12933-025-02895-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.